Clinical Trial

Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2024 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Root canal therapy (RCT) is a classical and effective treatment that is currently utilised in dental practice, offering high success rates for pulp and periapical diseases; however, teeth after RCT are susceptible to altered pulp defence and sensory function, even fractures, as a consequence of pulp loss. Furthermore, several studies have highlighted that the actual failure rate of standard root canal treatments performed in general practice is significantly higher than expected . Moreover, these treatments are lengthy and costly and are often subject to retreatment .Inherent in this procedure(rct) is loss of dental hard tissue and subsequent weakening of the treated tooth,making them more prone to fracture. Therefore, less invasive alternative strategies could be used to treat pulpitis, even when irreversible. Murray et al. proposed the term "Regenerative endodontic treatment (RET)" in 2007, based on a tissue engineering concept (stem cells, biomimetic scaffolds, and bioactive growth factors). The 2016 American Association of Endodontists (AAE) guidelines formally defined RET as a collection of "biologically based procedures designed to replace damaged tooth structures, including dentine and root structures, as well as cells of the pulp-dentine complex"
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-26.
Status change: Not Yet Recruiting → Recruiting 2024-08-01
Trial Details
NCT Number NCT06525844
Lead Sponsor Shaheed Zulfiqar Ali Bhutto Medical University
Conditions Symptomatic Irreversible Pulpitis
Enrollment 60 participants
Start Date 2024-08-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-05